NetraMark HoldingsAINMF -4.35%22 PB Ratio is 16.82 as of Jun. 27, 2026, which is 46% below its 10-year median of 30.88. GuruFocus rates AINMF with a GF Score™ of 22/100 and a GF Value™ of $0.21 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 611 Healthcare Providers & Services companies, NetraMark Holdings ranks worse than 97.22% on this metric.
NetraMark Holdings Inc stock PB Ratio (=23.24) is close to 2-year low of 23.24.
The historical rank and industry rank for NetraMark Holdings's PB Ratio or its related term are showing as below:
AINMF'
s PB Ratio Range Over the Past 10 Years
Min: 0.64 Med: 30.88 Max: 150.91
Current: 21.02
During the past 6 years, NetraMark Holdings's highest PB Ratio was 150.91. The lowest was 0.64. And the median was 30.88.
AINMF's PB Ratio is ranked worse than 97.22% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs AINMF: 21.02
During the past 12 months, NetraMark Holdings's average Book Value Per Share Growth Rate was 70.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -52.10% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of NetraMark Holdings was -32.40% per year. The lowest was -52.10% per year. And the median was -42.25% per year.
Back to Basics: PB Ratio
NetraMark Holdings (OTCPK:AINMF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
NetraMark Holdings PB Ratio Related Terms
NetraMark Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for NetraMark Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NetraMark Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
NetraMark Holdings (AINMF) has a PB Ratio of 16.82 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NetraMark Holdings and its competitors. This is 46% below median its historical median of 30.88. Over the past decade, NetraMark Holdings' PB Ratio has ranged from 0.64 to 150.91. According to the industry distribution chart, NetraMark Holdings ranks #594 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 97.2%.
Is NetraMark Holdings' PB Ratio too high?
NetraMark Holdings' current PB Ratio of 16.82 is 46% below median its 10-year median of 30.88. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 150.91. The Healthcare Providers & Services industry median PB Ratio is 1.98. NetraMark Holdings' value of 16.82 is 749.5% above this industry median. Based on the distribution chart, NetraMark Holdings ranks #594 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NetraMark Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #594 out of 611 companies for PB Ratio. This places NetraMark Holdings in the lower half of its industry. The industry median PB Ratio is 1.98. NetraMark Holdings' value of 16.82 is 749.5% above this benchmark. Historically, NetraMark Holdings' own PB Ratio has ranged from 0.64 to 150.91 over the past decade. While the company's 10-year median is 30.88 vs. the industry median of 1.98, NetraMark Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NetraMark Holdings's current PB Ratio of 16.82 is 749.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NetraMark Holdings and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NetraMark Holdings's current PB Ratio is 16.82, which is 46% below median its own 10-year median of 30.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.21, compared to a current price of $0.42 — trading 100.2% above its estimated fair value. The current PB Ratio is 16.82, which is 46% below median its 10-year median of 30.88 and 749.5% above the Healthcare Providers & Services industry median of 1.98. NetraMark Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current PB Ratio is 16.82 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NetraMark Holdings (AINMF) Overvalued in 2026?
Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued.
The current stock price of $0.42 is trading 100.2% above its estimated GF Value™ of $0.21.
GuruFocus considers NetraMark Holdings to be Significantly Overvalued.
Key valuation signals for AINMF:
PB Ratio: 16.82 (46% below median its 10-year median of 30.88)
GF Value™: $0.21 vs. price of $0.42 (100.2% above fair value)
Industry Position: 749.5% above the Healthcare Providers & Services median (#594 of 611)
No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
22GF Score
Get the complete analysis for AINMF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINMF has been successfully added to your 
